(Q67589160)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

1

P E Lønning

1 reference

15 September 2019

M. Dowsett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

A. Jones

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

D. Ekse

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

S. Jacobs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

F. McNeil

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

D. C. Johannessen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

T. J. Powles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446052

27 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1446052

27 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

15 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

57-62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1446052%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01831476

15 September 2019

exact match

0 references

cites work

Low-dose aminoglutethimide without steroid replacement in the treatment of postmenopausal women with advanced breast cancer

1 reference

12 December 2020

1 reference

12 December 2020

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

1 reference

12 December 2020

Endocrine treatment of breast cancer in women

1 reference

12 December 2020

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer

1 reference

12 December 2020

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

1 reference

12 December 2020

Plasma estrone-sulfate assessment of reduced estrogen production during treatment of metastatic breast carcinoma

1 reference

12 December 2020

Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione

1 reference

12 December 2020

Importance of estrogen sulfates in breast cancer

1 reference

12 December 2020

Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide

1 reference

12 December 2020

The influence of CGS 16949A on peripheral aromatisation in breast cancer patients

1 reference

12 December 2020

Inhibition of aromatase with CGS 16949A in postmenopausal women

1 reference

12 December 2020

Preliminary study of the treatment of advanced breast cancer in postmenopausal women with the aromatase inhibitor CGS 16949A

1 reference

12 December 2020

Aromatase inhibitors and the treatment of breast cancer

1 reference

12 December 2020

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

1 reference

12 December 2020

Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study

1 reference

12 December 2020

Aminoglutethimide as treatment of postmenopausal women with advanced breast carcinoma

1 reference

12 December 2020

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

12 December 2020

Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer

1 reference

12 December 2020

Assessment of response to therapy in advanced breast cancer

1 reference

12 December 2020

Additive effects of aminoglutethimide, testololactone, and 4-hydroxyandrostenedione as inhibitors of aromatase

1 reference

12 December 2020

Effects of aminoglutethimide on adrenal steroid secretion

1 reference

12 December 2020

Effects of aminoglutethimide on plasma estrone sulfate not caused by aromatase inhibition

1 reference

12 December 2020

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

1 reference

12 December 2020

Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer.

1 reference

12 December 2020

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

1 reference

12 December 2020

Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients

1 reference

12 December 2020

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

1 reference

12 December 2020